Literature DB >> 10559039

Pharmacogenomics. Interview by Clare Thompson.

W Sadee's.   

Abstract

Mesh：

Year:  1999        PMID： 10559039      PMCID： PMC1129064          DOI： 10.1136/bmj.319.7220.1286

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  14 in total

1.  Genetic control of isoniazid metabolism in man.

Authors:  D A EVANS; K A MANLEY; V A McKUSICK
Journal:  Br Med J       Date:  1960-08-13

2.  Microchip arrays put DNA on the spot.

Authors:  R F Service
Journal:  Science       Date:  1998-10-16       Impact factor: 47.728

3.  Genetic variation as a guide to drug development.

Authors:  P W Kleyn; E S Vesell
Journal:  Science       Date:  1998-09-18       Impact factor: 47.728

Review 4.  Genomics and drugs: finding the optimal drug for the right patient.

Authors:  W Sadée
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

5.  Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population.

Authors:  F Broly; A Gaedigk; M Heim; M Eichelbaum; K Morike; U A Meyer
Journal:  DNA Cell Biol       Date:  1991-10       Impact factor: 3.311

6.  Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation.

Authors:  B Schmid; J Bircher; R Preisig; A Küpfer
Journal:  Clin Pharmacol Ther       Date:  1985-12       Impact factor: 6.875

7.  Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians.

Authors:  H L Tai; E Y Krynetski; C R Yates; T Loennechen; M Y Fessing; N F Krynetskaia; W E Evans
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

8.  The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.

Authors:  S M de Morais; G R Wilkinson; J Blaisdell; K Nakamura; U A Meyer; J A Goldstein
Journal:  J Biol Chem       Date:  1994-06-03       Impact factor: 5.157

9.  Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.

Authors:  R M Weinshilboum; S L Sladek
Journal:  Am J Hum Genet       Date:  1980-09       Impact factor: 11.025

Review 10.  The Environmental Genome Project: functional analysis of polymorphisms.

Authors:  F P Guengerich
Journal:  Environ Health Perspect       Date:  1998-07       Impact factor: 9.031
View more
  8 in total

Review 1.  Genetics 101: detecting mutations in human genes.

Authors:  Alison Sinclair
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

2.  Pharmacogenomics and the evolution of healthcare : is it time for cost-effectiveness analysis at the individual level?

Authors:  Mohan V Bala; Gary A Zarkin
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

3.  Molecular interactions between dipeptides, drugs and the human intestinal H+ -oligopeptide cotransporter hPEPT1.

Authors:  Monica Sala-Rabanal; Donald D F Loo; Bruce A Hirayama; Eric Turk; Ernest M Wright
Journal:  J Physiol       Date:  2006-04-20       Impact factor: 5.182

Review 4.  Pharmacogenetics of response to statins: where do we stand?

Authors:  Anke-Hilse Maitland-van der Zee; Eric Boerwinkle
Journal:  Curr Atheroscler Rep       Date:  2005-05       Impact factor: 5.113

Review 5.  Pharmacogenomics: the promise of personalized medicine.

Authors:  L Mancinelli; M Cronin; W Sadée
Journal:  AAPS PharmSci       Date:  2000

Review 6.  Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines.

Authors:  Stefan Vegter; Cornelis Boersma; Mark Rozenbaum; Bob Wilffert; Gerjan Navis; Maarten J Postma
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

7.  cDNA microarray analysis of vascular gene expression after nitric oxide donor infusions in rats: implications for nitrate tolerance mechanisms.

Authors:  Ellen Q Wang; Woo-In Lee; Daniel Brazeau; Ho-Leung Fung
Journal:  AAPS PharmSci       Date:  2002

Review 8.  Advances in preclinical approaches to Chagas disease drug discovery.

Authors:  Fernando Villalta; Girish Rachakonda
Journal:  Expert Opin Drug Discov       Date:  2019-08-14       Impact factor: 6.098
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.